unknown
Stage
1
Investors
About
X4 Pharmaceuticals develops treatments targeting the CXCR4 receptor to address rare and severe diseases involving immune dysregulation and hematologic conditions.
Explore X4 Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.